361b
HIV-1 Gag-specific T cells in Semen but Not in Peripheral Blood of HIV High-risk Seronegative Men
Yan Ding*, G Diaz, J Czartoski, J Lee, H Zhu, T Zhu, and J McElrath
Fred Hutchinson Cancer Res Ctr, Univ of Washington, Seattle, US
Background: Mucosal exposures to HIV-1 in exposed
seronegative men who have sex with men (MSM) may lead to localized immunity,
which may serve as one mechanism for relative resistance to HIV-1 infection.
In prior studies, we were unable to consistently demonstrate HIV-specific
interferon (IFN) -g-secreting T cells
in the peripheral blood of most high risk exposed seronegative MSM. In this
study we examined the possibility that HIV-specific T cells may preferentially
localize in the lower genital tract of exposed seronegative MSM.
Methods: We measured HIV-specific T cells by IFN-g enzyme-linked immunosorbent (ELISpot) assay
in the semen of 18 high-risk exposed seronegative MSM who did not possess the
CCR5-Δ32 polymorphism. We contrasted these results with measurements in
22 MSM with chronic HIV infection. Seminal mononuclear cells (SMC) were
isolated from fresh ejaculate by pronase treatment and standard density
gradient centrifugation and examined in fresh assays.
Results: We found that, while HIV-infected men all
had HIV-1 Gag-specific responses in their blood, only 59% had Gag-specific
responses in seminal T cells. In contrast, while no exposed seronegative men
had Gag-specific responses in their blood, 27.8% had seminal Gag-specific T
cells. In some cases, detection of mucosal T cell responses appeared to be
associated with recent HIV exposure or re-exposure.
Conclusions: These findings suggest that repeated
mucosal HIV-1 exposure can induce localized HIV-specific T cells, and that
these cells are unlikely to be detected in peripheral blood. Further
longitudinal studies are required to understand whether these responses are
durable and correlate with reduced susceptibility to HIV infection in high risk
men.
|